Models/paper/2026-09-21

Anthropic's AI Developments: Research on Model Intent and Drug Discovery Venture

Anthropic is reportedly engaged in dual AI initiatives, with scientists investigating and demonstrating the ability to alter the intentions of its Claude AI models. Concurrently, the company has partnered with ByteDance to enter the AI drug discovery sector, an area noted for significant data bottlenecks.

2 articles from 1 outlet covered this story. The underlying claim is sourced from a paper.

What do all outlets agree on?

1 outlet covered “Anthropic's AI Developments: Research on Model Intent and Drug Discovery Venture”. All of them report the following:

  • Anthropic's Claude AI models are subject of research into their intentions
  • Scientists have demonstrated the ability to intervene and alter AI model intentions
  • Anthropic and ByteDance have partnered to enter AI drug discovery
  • AI drug discovery faces critical data bottlenecks

Which outlets covered this?

All 2 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

What related stories are there?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.